FORT WORTH, Tex.—A five-year, multi-million dollar capital investment program recently initiated by CoorsTek Medical will support growing worldwide demand for the company’s ceramic components used in hip replacements and turn-key hip arthroplasty. According to a release from CoorsTek, the investment funds a twenty-fold production expansion of these products as major medical device manufacturers adopt the company’s CeraSurf® medical-grade ceramics.

The CoorsTek Medical CeraSurf alumina matrix composite is said to be CE-compliant and substantially equivalent to the latest generation material used in ceramic hip implants today. Since 2011, more than 7,000 CeraSurf hip balls and acetabular liners reportedly have been sold for distribution across key global markets.

CoorsTek produces critical-duty products and components for some 10,000 customers from its portfolio of more than 300 advanced materials, according to the release. CoorsTek Medical (coorstekmedical.com) provides “specialized OEM medical device solutions designed around durable, biocompatible ceramic technology,” and reportedly delivers “more than 1,000,000 components annually to the world’s leading medical device manufacturers.”

“As we engage medical innovators and key opinion leaders globally, they are applying the unique, high performance benefits of our ceramic materials to improve the longevity and lifestyle for more patients each year,” stated Jonathan Coors, CEO of CoorsTek Medical, in the press release. “Our valued partners deserve a choice and will be successful with a trusted partner who embraces today’s dynamic healthcare economy. This investment demonstrates the CoorsTek Medical commitment to being that partner of choice for implant-grade ceramic materials which make lives measurably better.”